Production (Stage)
Encompass Health Corporation
EHC
$118.90
$0.290.24%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.46B | 1.41B | 1.35B | 1.30B | 1.32B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.46B | 1.41B | 1.35B | 1.30B | 1.32B |
| Cost of Revenue | 824.50M | 819.10M | 792.70M | 758.10M | 770.10M |
| Gross Profit | 630.90M | 585.90M | 558.30M | 543.10M | 545.90M |
| SG&A Expenses | 67.20M | 69.20M | 68.40M | 64.70M | 64.20M |
| Depreciation & Amortization | 79.20M | 78.00M | 78.40M | 72.90M | 70.30M |
| Other Operating Expenses | 217.50M | 206.40M | 202.40M | 189.90M | 193.50M |
| Total Operating Expenses | 1.19B | 1.17B | 1.14B | 1.09B | 1.10B |
| Operating Income | 267.00M | 232.30M | 209.10M | 215.60M | 217.90M |
| Income Before Tax | 238.60M | 201.40M | 183.80M | 186.00M | 178.40M |
| Income Tax Expenses | 41.60M | 37.60M | 36.00M | 38.30M | 38.30M |
| Earnings from Continuing Operations | 197.00M | 163.80M | 147.80M | 147.70M | 140.10M |
| Earnings from Discontinued Operations | -500.00K | 400.00K | -700.00K | -1.20M | -1.30M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -45.00M | -43.30M | -38.90M | -32.40M | -26.30M |
| Net Income | 151.50M | 120.90M | 108.20M | 114.10M | 112.50M |
| EBIT | 267.00M | 232.30M | 209.10M | 215.60M | 217.90M |
| EBITDA | 346.20M | 310.30M | 287.50M | 288.50M | 288.20M |
| EPS Basic | 1.50 | 1.20 | 1.08 | 1.13 | 1.12 |
| Normalized Basic EPS | 1.04 | 0.83 | 0.76 | 0.84 | 0.92 |
| EPS Diluted | 1.48 | 1.18 | 1.06 | 1.12 | 1.10 |
| Normalized Diluted EPS | 1.02 | 0.81 | 0.75 | 0.82 | 0.90 |
| Average Basic Shares Outstanding | 100.50M | 100.00M | 99.90M | 99.90M | 99.80M |
| Average Diluted Shares Outstanding | 102.10M | 102.30M | 102.10M | 102.00M | 102.20M |
| Dividend Per Share | 0.17 | 0.17 | 0.17 | 0.15 | 0.15 |
| Payout Ratio | 11.88% | 14.06% | 13.86% | 13.06% | 14.13% |